Molecular and hematological studies in a cohort of beta zero South East Asia deletion (β°-thal SEA) from Malaysian perspective.

Autor: Yasin NM; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Abdul Hamid FS; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Hassan S; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Sudin A; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Yassim H; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Mohd Sahid EN; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Mat Yusoff Y; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Esa E; Hematology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health (Malaysia), Kuala Lumpur, Malaysia., Saleem M; Advanced Genomics Sdn Bhd, Petaling Jaya, Malaysia.

Publikováno v: Frontiers in pediatrics [Front Pediatr] 2022 Nov 30; Vol. 10, pp. 974496. Date of Electronic Publication: 2022 Nov 30 (Print Publication: 2022).

Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response.

Autor: Mohd Yacob A; Haematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, U13/52 Setia Alam, 40170, Shah Alam, Selangor, Malaysia. aliza.yacob@moh.gov.my., Muhamad NA; Sector for Evidence Based Healthcare, National Institutes of Health, Ministry of Health, Shah Alam, Selangor, Malaysia., Chang KM; Haematology Department, Hospital Ampang, Ministry of Health, Ampang, Selangor, Malaysia., Akmal Hisham H; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, Shah Alam, Selangor, Malaysia., Mat Yusoff Y; Haematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, U13/52 Setia Alam, 40170, Shah Alam, Selangor, Malaysia., Ibrahim L; Special Resource Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, Shah Alam, Selangor, Malaysia.

Publikováno v: BMC cancer [BMC Cancer] 2022 Mar 26; Vol. 22 (1), pp. 332. Date of Electronic Publication: 2022 Mar 26.

Construction of a microRNA-mRNA Regulatory Network in De Novo Cytogenetically Normal Acute Myeloid Leukemia Patients.

Autor: Esa E; Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia., Hashim AK; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Mohamed EHM; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Zakaria Z; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Abu Hassan AN; Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia., Mat Yusoff Y; Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia., Kamaluddin NR; Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia., Abdul Rahman AZ; Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia., Chang KM; Hospital Ampang, Jalan Mewah Utara, Pandan Mewah, Ampang, Malaysia., Mohamed R; Hospital Ampang, Jalan Mewah Utara, Pandan Mewah, Ampang, Malaysia., Subbiah I; Hospital Sultanah Aminah, Bangunan Induk, Jalan Persiaran Abu Bakar Sultan, Johor Bahru, Malaysia., Jamian E; Hospital Sultanah Aminah, Bangunan Induk, Jalan Persiaran Abu Bakar Sultan, Johor Bahru, Malaysia., Ho CS; Hospital Sultanah Aminah, Bangunan Induk, Jalan Persiaran Abu Bakar Sultan, Johor Bahru, Malaysia., Lim SM; Hospital Sultanah Aminah, Bangunan Induk, Jalan Persiaran Abu Bakar Sultan, Johor Bahru, Malaysia., Lau PC; Department of Surgery, Faculty of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur, Malaysia., Pung YF; Department of Biomedical Science, University of Nottingham, Semenyih, Malaysia., Zain SM; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Publikováno v: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2021 Mar; Vol. 25 (3), pp. 199-210.

Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia

Autor: Mat Yusoff Y; Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, Wilayah Persekutuan Kuala Lumpur, Malaysia. Email: yuslina@imr.gov.my, Abu Seman Z, Othman N, Kamaluddin NR, Esa E, Zulkiply NA, Abdullah J, Zakaria Z

Publikováno v: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2018 Dec 25; Vol. 19 (12), pp. 3317-3320. Date of Electronic Publication: 2018 Dec 25.

Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.

Autor: Wang, Yihua^1,2 (AUTHOR), Travers, Richard J.^1,3 (AUTHOR), Farrell, Alanna⁴ (AUTHOR), Lu, Qing¹ (AUTHOR), Bays, Jennifer L.⁴ (AUTHOR), Stepanian, Alec¹ (AUTHOR), Chen, Christopher⁴ (AUTHOR), Jaffe, Iris Z.¹ (AUTHOR) ijaffe@tuftsmedicalcenter.org

Publikováno v: PLoS ONE. 11/20/2023, Vol. 18 Issue 11, p1-19. 19p.